JP2014521313A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521313A5 JP2014521313A5 JP2014519454A JP2014519454A JP2014521313A5 JP 2014521313 A5 JP2014521313 A5 JP 2014521313A5 JP 2014519454 A JP2014519454 A JP 2014519454A JP 2014519454 A JP2014519454 A JP 2014519454A JP 2014521313 A5 JP2014521313 A5 JP 2014521313A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- cells
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091033319 polynucleotide Proteins 0.000 claims description 13
- 102000040430 polynucleotide Human genes 0.000 claims description 13
- 239000002157 polynucleotide Substances 0.000 claims description 13
- 239000012634 fragment Substances 0.000 claims description 12
- 239000000427 antigen Substances 0.000 claims description 10
- 108091007433 antigens Proteins 0.000 claims description 10
- 102000036639 antigens Human genes 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 101150081864 Spr gene Proteins 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 230000035772 mutation Effects 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 claims 14
- 238000000034 method Methods 0.000 claims 6
- 235000001014 amino acid Nutrition 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 210000004899 c-terminal region Anatomy 0.000 claims 2
- 239000012636 effector Substances 0.000 claims 2
- 239000001963 growth medium Substances 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
- 101150052672 IGS1 gene Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940034982 antineoplastic agent Drugs 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 229920001427 mPEG Polymers 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 210000001322 periplasm Anatomy 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 125000006853 reporter group Chemical group 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 108700012359 toxins Proteins 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 2
- 108010078959 C-terminal processing peptidase Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11173880.3 | 2011-07-13 | ||
| EP11173880 | 2011-07-13 | ||
| PCT/EP2012/002945 WO2013007388A1 (en) | 2011-07-13 | 2012-07-13 | Bacterial host strain expressing recombinant dsbc |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017209932A Division JP2018019719A (ja) | 2011-07-13 | 2017-10-31 | 組換えDsbCを発現する細菌宿主系統 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014521313A JP2014521313A (ja) | 2014-08-28 |
| JP2014521313A5 true JP2014521313A5 (OSRAM) | 2017-03-09 |
| JP6431370B2 JP6431370B2 (ja) | 2018-11-28 |
Family
ID=46545736
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014519454A Active JP6431370B2 (ja) | 2011-07-13 | 2012-07-13 | 組換えDsbCを発現する細菌宿主系統 |
| JP2017209932A Pending JP2018019719A (ja) | 2011-07-13 | 2017-10-31 | 組換えDsbCを発現する細菌宿主系統 |
| JP2019200029A Active JP7062626B2 (ja) | 2011-07-13 | 2019-11-01 | 組換えDsbCを発現する細菌宿主系統 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017209932A Pending JP2018019719A (ja) | 2011-07-13 | 2017-10-31 | 組換えDsbCを発現する細菌宿主系統 |
| JP2019200029A Active JP7062626B2 (ja) | 2011-07-13 | 2019-11-01 | 組換えDsbCを発現する細菌宿主系統 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US9725516B2 (OSRAM) |
| EP (2) | EP3339325A1 (OSRAM) |
| JP (3) | JP6431370B2 (OSRAM) |
| KR (1) | KR102023786B1 (OSRAM) |
| CN (1) | CN103649124B (OSRAM) |
| AU (1) | AU2012283388B2 (OSRAM) |
| BR (1) | BR112013032871B1 (OSRAM) |
| CA (1) | CA2841824C (OSRAM) |
| CY (1) | CY1119985T1 (OSRAM) |
| DK (1) | DK2731973T3 (OSRAM) |
| EA (1) | EA031449B1 (OSRAM) |
| ES (1) | ES2659155T3 (OSRAM) |
| HR (1) | HRP20180226T1 (OSRAM) |
| HU (1) | HUE035674T2 (OSRAM) |
| IL (1) | IL229947B (OSRAM) |
| IN (1) | IN2014DN00202A (OSRAM) |
| LT (1) | LT2731973T (OSRAM) |
| ME (1) | ME02957B (OSRAM) |
| MX (1) | MX348738B (OSRAM) |
| NO (1) | NO2731973T3 (OSRAM) |
| PL (1) | PL2731973T3 (OSRAM) |
| PT (1) | PT2731973T (OSRAM) |
| RS (1) | RS56926B1 (OSRAM) |
| SG (1) | SG10201807560XA (OSRAM) |
| SI (1) | SI2731973T1 (OSRAM) |
| SM (1) | SMT201800068T1 (OSRAM) |
| WO (1) | WO2013007388A1 (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY166021A (en) * | 2007-03-22 | 2018-05-21 | Biogen Ma Inc | Binding proteins,including antibodies,antibody derivatives and antibody fragments,that specifically bind cd154 and uses thereof |
| SMT201800549T1 (it) | 2009-09-24 | 2018-11-09 | Ucb Biopharma Sprl | Ceppo batterico per espressione di proteina ricombinante, avente attivita' di chaperone a conservazione di degp carente di proteasi, e geni tsp e ptr con knockout |
| GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| MX348738B (es) | 2011-07-13 | 2017-06-27 | Ucb Pharma Sa | Cepa huesped bacteriana que expresa dsbc recombinante. |
| GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
| GB201223276D0 (en) * | 2012-12-21 | 2013-02-06 | Ucb Pharma Sa | Antibodies and methods of producing same |
| DK3237432T3 (da) | 2014-12-22 | 2023-11-20 | UCB Biopharma SRL | Proteinfremstilling |
| KR101810778B1 (ko) * | 2015-06-23 | 2017-12-20 | 서울대학교산학협력단 | Cd154 결합 폴리펩타이드 및 그 용도 |
| CN108495653A (zh) | 2016-01-27 | 2018-09-04 | 免疫医疗有限责任公司 | 用于制备具有定义的糖基化模式抗体的方法 |
| EP3774926A1 (en) | 2018-04-05 | 2021-02-17 | Bio-Rad ABD Serotec GmbH | Display systems for proteins of interest |
| WO2020096959A1 (en) | 2018-11-05 | 2020-05-14 | Genentech, Inc. | Methods of producing two chain proteins in prokaryotic host cells |
| CN109371049A (zh) * | 2018-11-14 | 2019-02-22 | 天津大学 | 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用 |
| EP3942079A1 (en) | 2019-03-18 | 2022-01-26 | Bio-Rad ABD Serotec GmbH | Protection of spytag-containing periplasmic fusion proteins from protease tsp and ompt degradation |
| JP7259131B2 (ja) * | 2019-08-05 | 2023-04-17 | ワッカー ケミー アクチエンゲゼルシャフト | 発酵法で組換えタンパク質を放出する細菌株 |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| GB8907617D0 (en) | 1989-04-05 | 1989-05-17 | Celltech Ltd | Drug delivery system |
| US5264365A (en) | 1990-11-09 | 1993-11-23 | Board Of Regents, The University Of Texas System | Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides |
| US5508192A (en) | 1990-11-09 | 1996-04-16 | Board Of Regents, The University Of Texas System | Bacterial host strains for producing proteolytically sensitive polypeptides |
| GB9112536D0 (en) | 1991-06-11 | 1991-07-31 | Celltech Ltd | Chemical compounds |
| US5474771A (en) | 1991-11-15 | 1995-12-12 | The Trustees Of Columbia University In The City Of New York | Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same |
| JPH08500963A (ja) | 1992-04-28 | 1996-02-06 | ザ・リージェンツ・オブ・ザ・ユニヴァーシティー・オブ・ミシガン | ヒューマンcrabp−▲i▼及びcrabp−▲ii▼ |
| GB9215540D0 (en) | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
| US5304472A (en) | 1992-11-20 | 1994-04-19 | Genentech, Inc. | Method of controlling polypeptide production in bacterial cells |
| US5639635A (en) | 1994-11-03 | 1997-06-17 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US6027888A (en) | 1996-04-05 | 2000-02-22 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells |
| GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
| US6083715A (en) | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| JP2000083670A (ja) | 1998-09-09 | 2000-03-28 | Hsp Kenkyusho:Kk | DsbA/DsbB/DsbC/DsbD発現プラスミド |
| JP2003503074A (ja) | 1999-06-29 | 2003-01-28 | シガ・テクノロジーズ,インコーポレイテッド | Degpプロテアーゼインヒビター類の分析方法 |
| GB0006398D0 (en) | 2000-03-16 | 2000-05-03 | Novartis Ag | Organic compounds |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| EP1314037A2 (en) | 2000-09-01 | 2003-05-28 | Biogen, Inc. | Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| AU8867501A (en) | 2000-09-01 | 2002-03-13 | Biogen Inc | Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| US7041479B2 (en) | 2000-09-06 | 2006-05-09 | The Board Of Trustess Of The Leland Stanford Junior University | Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| DK1356052T3 (da) | 2000-12-14 | 2008-12-08 | Genentech Inc | Produktion af hele antistoffer i prokaryotiske celler |
| BR0116680A (pt) * | 2000-12-14 | 2005-04-05 | Genentech Inc | Linhagem de e. coli e método de produção de um polipeptìdeo |
| TWI327597B (en) | 2001-08-01 | 2010-07-21 | Centocor Inc | Anti-tnf antibodies, compositions, methods and uses |
| EP1427744B1 (en) | 2001-08-27 | 2007-12-26 | Genentech, Inc. | A system for antibody expression and assembly |
| GB0124317D0 (en) | 2001-10-10 | 2001-11-28 | Celltech R&D Ltd | Biological products |
| CN1585822A (zh) | 2001-11-16 | 2005-02-23 | 拜奥根Idec公司 | 抗体的多顺反子表达 |
| GB0129105D0 (en) * | 2001-12-05 | 2002-01-23 | Celltech R&D Ltd | Expression control using variable intergenic sequences |
| DE60305919T2 (de) | 2002-06-28 | 2007-01-18 | Domantis Limited, Cambridge | Dual-specifische liganden mit erhöhter halbwertszeit |
| AU2003287345A1 (en) | 2002-10-31 | 2004-06-07 | Genentech, Inc. | Methods and compositions for increasing antibody production |
| ES2374068T3 (es) | 2002-12-03 | 2012-02-13 | Ucb Pharma, S.A. | Ensayo para identificar células productoras de anticuerpos. |
| GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
| NZ544486A (en) | 2003-06-13 | 2009-04-30 | Biogen Idec Inc | Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof |
| CA2529819A1 (en) | 2003-06-30 | 2004-09-23 | Domantis Limited | Pegylated single domain antibodies |
| GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| CA2533593A1 (en) | 2003-07-26 | 2005-02-10 | Biogen Idec Ma Inc. | Altered antibodies having improved antigen-binding affinity |
| EA014226B1 (ru) | 2004-07-26 | 2010-10-29 | Байоджен Айдек Ма Инк. | Антитела к cd154, их фрагменты и способы применения антител и фрагментов |
| EP1789446A2 (en) * | 2004-09-02 | 2007-05-30 | Genentech, Inc. | Heteromultimeric molecules |
| US7563443B2 (en) | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
| GB0425534D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Process for obtaining antibodies |
| GB0520169D0 (en) | 2005-10-04 | 2005-11-09 | Celltech R&D Ltd | Biological products |
| MY166021A (en) | 2007-03-22 | 2018-05-21 | Biogen Ma Inc | Binding proteins,including antibodies,antibody derivatives and antibody fragments,that specifically bind cd154 and uses thereof |
| CA2700714C (en) | 2007-09-26 | 2018-09-11 | Ucb Pharma S.A. | Dual specificity antibody fusions |
| US7662587B1 (en) | 2009-03-05 | 2010-02-16 | E. I. Du Pont De Nemours And Company | Gene knockout mutations that increase peptide production |
| SMT201800549T1 (it) | 2009-09-24 | 2018-11-09 | Ucb Biopharma Sprl | Ceppo batterico per espressione di proteina ricombinante, avente attivita' di chaperone a conservazione di degp carente di proteasi, e geni tsp e ptr con knockout |
| US8470552B2 (en) | 2009-10-12 | 2013-06-25 | Keck Graduate Institute | Strategy to reduce lactic acid production and control PH in animal cell culture |
| CA2780143A1 (en) | 2009-11-05 | 2011-05-12 | Genentech, Inc. | Methods and composition for secretion of heterologous polypeptides |
| GB201000588D0 (en) * | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000587D0 (en) * | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000591D0 (en) * | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201001791D0 (en) | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
| GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| MX348738B (es) * | 2011-07-13 | 2017-06-27 | Ucb Pharma Sa | Cepa huesped bacteriana que expresa dsbc recombinante. |
| EP2546267A1 (en) | 2011-07-13 | 2013-01-16 | UCB Pharma S.A. | Bacterial host strain expressing recombinant DsbC |
| GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
-
2012
- 2012-07-13 MX MX2014000302A patent/MX348738B/es active IP Right Grant
- 2012-07-13 EA EA201490274A patent/EA031449B1/ru not_active IP Right Cessation
- 2012-07-13 PL PL12737492T patent/PL2731973T3/pl unknown
- 2012-07-13 JP JP2014519454A patent/JP6431370B2/ja active Active
- 2012-07-13 SG SG10201807560XA patent/SG10201807560XA/en unknown
- 2012-07-13 BR BR112013032871-1A patent/BR112013032871B1/pt active IP Right Grant
- 2012-07-13 PT PT127374924T patent/PT2731973T/pt unknown
- 2012-07-13 HU HUE12737492A patent/HUE035674T2/en unknown
- 2012-07-13 AU AU2012283388A patent/AU2012283388B2/en active Active
- 2012-07-13 RS RS20180171A patent/RS56926B1/sr unknown
- 2012-07-13 CA CA2841824A patent/CA2841824C/en active Active
- 2012-07-13 IN IN202DEN2014 patent/IN2014DN00202A/en unknown
- 2012-07-13 ES ES12737492.4T patent/ES2659155T3/es active Active
- 2012-07-13 LT LTEP12737492.4T patent/LT2731973T/lt unknown
- 2012-07-13 HR HRP20180226TT patent/HRP20180226T1/hr unknown
- 2012-07-13 SM SM20180068T patent/SMT201800068T1/it unknown
- 2012-07-13 DK DK12737492.4T patent/DK2731973T3/da active
- 2012-07-13 ME MEP-2018-33A patent/ME02957B/me unknown
- 2012-07-13 SI SI201231206T patent/SI2731973T1/en unknown
- 2012-07-13 US US14/131,994 patent/US9725516B2/en active Active
- 2012-07-13 EP EP17196968.6A patent/EP3339325A1/en not_active Withdrawn
- 2012-07-13 EP EP12737492.4A patent/EP2731973B1/en active Active
- 2012-07-13 KR KR1020137034718A patent/KR102023786B1/ko active Active
- 2012-07-13 NO NO12737492A patent/NO2731973T3/no unknown
- 2012-07-13 WO PCT/EP2012/002945 patent/WO2013007388A1/en not_active Ceased
- 2012-07-13 CN CN201280034512.9A patent/CN103649124B/zh active Active
-
2013
- 2013-12-17 IL IL22994713A patent/IL229947B/en active IP Right Grant
-
2017
- 2017-08-03 US US15/667,649 patent/US9957328B2/en active Active
- 2017-10-31 JP JP2017209932A patent/JP2018019719A/ja active Pending
-
2018
- 2018-02-15 CY CY20181100192T patent/CY1119985T1/el unknown
-
2019
- 2019-11-01 JP JP2019200029A patent/JP7062626B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521313A5 (OSRAM) | ||
| Silva et al. | Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses | |
| JP2021020905A5 (OSRAM) | ||
| TWI713942B (zh) | 與集落刺激因子1受體(csf1r)結合之抗體類 | |
| WO2021244089A1 (zh) | 新型冠状病毒(sars-cov-2)刺突蛋白结合分子及其应用 | |
| HRP20180226T1 (hr) | Bakterijski soj domaćina koji eksprimira rekombinantnu dsbc | |
| JP2018502572A5 (OSRAM) | ||
| JP2005120106A5 (OSRAM) | ||
| KR101796689B1 (ko) | 안정화된 면역글로불린가변도메인 선별방법 및 선별된 도메인의 응용 | |
| JP2010273685A5 (OSRAM) | ||
| JP2007530435A5 (OSRAM) | ||
| JP2020500510A5 (OSRAM) | ||
| JP2011526480A5 (OSRAM) | ||
| JP2008301822A5 (OSRAM) | ||
| JP2009511000A5 (OSRAM) | ||
| KR20180077144A (ko) | 신규 항체 라이브러리 제조방법 및 이로부터 제조된 라이브러리 | |
| WO2022061594A1 (zh) | 新型冠状病毒(sars-cov-2)刺突蛋白结合分子及其应用 | |
| JP2012524524A5 (OSRAM) | ||
| CA2636075A1 (en) | Chimaeric fusion protein with superior chaperone and folding activities | |
| JP2011523849A5 (OSRAM) | ||
| CN110964110A (zh) | 抗EGFR人源化的单域抗体、Fc融合蛋白、重链Fab蛋白及其应用 | |
| CN106928364B (zh) | 一种FAP纳米抗体Nb26 | |
| JP2010279373A5 (OSRAM) | ||
| CN113677704B (zh) | Psma抗体及其应用 | |
| JP2008507253A5 (OSRAM) |